Wu Zhaogui, Wu Dan, Chen Shuohua, Xu Sichi, Zhang Shunming, Wu Shouling
Department of Cardiology, Xiangyang No. 1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei, 441000, People's Republic of China.
Department of Pediatrics, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, People's Republic of China.
J Inflamm Res. 2024 Dec 21;17:11347-11356. doi: 10.2147/JIR.S488928. eCollection 2024.
This study aimed to longitudinally investigate the association between circulating neutrophil count and the progression of arterial stiffness and to ascertain whether resting heart rate (RHR) mediates this association.
The current study included 56,760 participants with brachial-ankle pulse wave velocity (baPWV) measurements from a real-life, prospective cohort in China. The associations of circulating neutrophil (exposure) with baseline baPWV, baPWV progression, and arterial stiffness (outcomes), as well as RHR (mediator) were assessed using multivariable linear and Cox regression models and mediation analysis.
After adjusting for cardiometabolic risk factors, for each 1-SD increase in neutrophil count, the corresponding increase was 13.5 cm/s (95% CI, 11.1 to 15.9 cm/s, <0.001) for the baseline baPWV and 3.10 cm/s (95% CI, 1.51 to 4.69, <0.001) for the annual change in baPWV. Over a median follow-up period of 4.08 (IQR: 2.37 to 6.21) years, there were 3,376 incident cases of arterial stiffness among the 23,263 participants. Each 1-SD increase in neutrophil count was associated with a 7% increase in the risk of developing arterial stiffness (HR: 1.07; 95% CI: 1.04 to 1.10, <0.001) in the multivariable-adjusted model. In the mediation analyses, 20.0% (95% CI: 16.8% to 24.2%), 12.6% (95% CI: 8.16% to 26.4%), and 16.7% (95% CI: 9.94% to 51.0%) of the observed associations of neutrophil counts with baPWV at baseline, baPWV progression and developing arterial stiffness, respectively, were mediated by RHR.
The present study underlines that circulating neutrophil count is significantly associated with arterial stiffness progression and that the RHR is, in part, a mediator of this association.
本研究旨在纵向调查循环中性粒细胞计数与动脉僵硬度进展之间的关联,并确定静息心率(RHR)是否介导这种关联。
本研究纳入了来自中国一项真实生活前瞻性队列的56760名进行了臂踝脉搏波速度(baPWV)测量的参与者。使用多变量线性和Cox回归模型以及中介分析评估循环中性粒细胞(暴露因素)与基线baPWV、baPWV进展和动脉僵硬度(结局)以及RHR(中介因素)之间的关联。
在调整了心血管代谢危险因素后,中性粒细胞计数每增加1个标准差,基线baPWV相应增加13.5 cm/s(95%CI:11.1至15.9 cm/s,<0.001),baPWV的年变化量相应增加3.10 cm/s(95%CI:1.51至4.69,<0.001)。在中位随访期4.08(IQR:2.37至6.21)年期间,23263名参与者中有3376例发生动脉僵硬度事件。在多变量调整模型中,中性粒细胞计数每增加1个标准差,发生动脉僵硬度的风险增加7%(HR:1.07;95%CI:1.04至1.10,<0.001)。在中介分析中,观察到的中性粒细胞计数与基线baPWV、baPWV进展和发生动脉僵硬度之间的关联中,分别有20.0%(95%CI:16.8%至24.2%)﹑12.6%(95%CI:8.16%至26.4%)和16.7%(95%CI:9.94%至51.0%)由RHR介导。
本研究强调循环中性粒细胞计数与动脉僵硬度进展显著相关,且RHR部分介导了这种关联。